Cargando…
Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study
OBJECTIVES: Dyspnoea is one of the symptoms frequently encountered after treatment with chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). Long-term data on mild to moderately severe cardiac events as underlying cause of dyspnoea in patients with stage III NSCLC are lacking. Th...
Autores principales: | Degens, Juliette, De Ruysscher, D, Houben, Ruud, Kietselaer, Bastiaan, Bootsma, Gerben, Hendriks, Lizza, Huijbers, Ellen, Schols, Annemie, Dingemans, Anne-Marie C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523207/ https://www.ncbi.nlm.nih.gov/pubmed/32988942 http://dx.doi.org/10.1136/bmjopen-2019-036492 |
Ejemplares similares
-
Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review
por: Brouns, Anita, et al.
Publicado: (2021) -
A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer
por: Dingemans, Anne-Marie C., et al.
Publicado: (2014) -
Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Haiyan, et al.
Publicado: (2022) -
Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
por: Hendriks, Lizza E. L., et al.
Publicado: (2018) -
The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
por: Degens, Juliette H.R.J., et al.
Publicado: (2021)